Lineage Cell Therapeutics Inc
TASE:LCTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
|
P
|
PGF Capital Bhd
KLSE:PGF
|
MY |
|
Saratoga Investama Sedaya Tbk PT
F:ZY8
|
ID |
|
Keihan Holdings Co Ltd
F:59X
|
JP |
|
Magis SpA
F:ZF6
|
IT |
|
P
|
Pandora A/S
F:3P7
|
DK |
|
Aditya Birla Sun Life AMC Ltd
NSE:ABSLAMC
|
IN |
|
C
|
CEL-SCI Corp
AMEX:CVM
|
US |
|
Fermiere du Casino Municipal Cannes SA
PAR:FCMC
|
FR |
|
I
|
Ibersol SGPS SA
ELI:IBS
|
PT |
|
C
|
Carlos Casado SA
BCBA:CADO
|
AR |
|
Prominence Energy Ltd
ASX:PRM
|
AU |
|
BKW AG
SIX:BKW
|
CH |
|
Thomson Medical Group Ltd
F:3H5
|
SG |
|
Santen Pharmaceutical Co Ltd
F:SZD
|
JP |
|
L
|
LG Corp
KRX:003555
|
KR |
|
Samsung C&T Corp
KRX:028260
|
KR |
|
A
|
AmmPower Corp
F:601A
|
CA |
|
Marr SpA
MIL:MARR
|
IT |
|
Hera SpA
MIL:HER
|
IT |
|
Innocan Pharma Corp
OTC:INNPF
|
IL |
|
S
|
Sabre Insurance Group PLC
F:18M
|
UK |
|
P
|
Pureun Mutual Savings Bank
KOSDAQ:007330
|
KR |
|
D
|
Daishin Securities Co Ltd
KRX:003545
|
KR |
Bankruptcy Probability
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lineage Cell Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
250.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
500.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
234.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
94.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lineage Cell Therapeutics Inc has total debt of 15k USD. This includes both short-term (0 USD) and long-term (15k USD) debt.
You can find a full breakdown on its Balance Sheet.